首页  期刊介绍 征稿简则 编委会 期刊征订 广告服务 留言板 联系我们 English

中国应用生理学杂志 ›› 2021, Vol. 37 ›› Issue (3): 230-234.doi: 10.12047/j.cjap.6034.2021.010

• 研究论文 • 上一篇    下一篇

糖尿病大鼠弓状核-海马肥胖抑素通路构成及对胃运动和胃排空的影响

郜慧英1, 周艳1, 高洁1, 李颜君1, 孙向荣2△   

  1. 1. 菏泽医学专科学校护理系, 山东 菏泽 274000;
    2. 青岛大学基础医学院生理学与病理生理学系, 山东 青岛 266071
  • 出版日期:2021-05-28 发布日期:2021-08-09
  • 通讯作者: Tel: 0532-82991713; E- mail: sunbetty@163.com
  • 基金资助:
    *国家自然科学基金资助项目(31971060);国家青年科学基金项目(81100260)

Effects of ARC-hippocampus obestatin neural pathway on gastric motility and gastric emptying in diabetic rats

GAO Hui-ying 1, ZHOU Yan 1, GAO Jie 1, LI Yan-jun 1, SUN Xiang-rong2△   

  1. 1. Department of Nursing, Heze Medical College, Heze 274000;
    2. Department of Physiology and Pathophysiology, School of Basic Medicine, Qingdao University, Qingdao 266071, China
  • Online:2021-05-28 Published:2021-08-09

摘要: 目的: 探究糖尿病大鼠弓状核(ARC)-海马肥胖抑素(obestatin)神经通路构成,以及该通路对大鼠胃运动、胃排空的影响。方法: 健康雄性Wistar大鼠采用果糖溶液诱导胰岛素抵抗加腹腔注射链脲佐菌素的方法制备糖尿病模型,造模之后,随机分为5组:对照组(NS组)、0.1、1和10 pmol obestatin组、obestatin+NBI27914组,每组7只;各组通过置管分别向海马内注射0.5 μl 生理盐水(NS)、obestatin(0.1 pmol、1 pmol、10 pmol)和混合液(10 pmol obestatin + 60 pmol NBI27914),给药后立即记录大鼠胃运动,15 min后进行胃排空研究;通过荧光金(FG)逆行追踪及免疫组化方法比较正常及糖尿病大鼠ARC-海马obestatin神经通路构及ARC obestatin mRNA表达的异同。结果: 与正常大鼠相比,糖尿病大鼠ARC FG/obestatin双标神经元数目显著减少(P<0.05),ARC obestatin mRNA表达量显著下降(P<0.05);obestatin各组可剂量依赖性的抑制大鼠胃运动及胃排空(P<0.05~0.01),obestatin的这些效应可被促肾上腺皮质激素受体1(CRFR1)阻断剂NBI27914部分阻断(P<0.05);obestatin对糖尿病大鼠胃运动和胃排空的抑制效应显著减弱(P<0.05)。结论: ARC-海马之间存在obestatin神经和功能通路,参与糖尿病大鼠胃运动及胃排空调控,且CRFR1信号通路参与该过程。该通路功能的减弱可能参与了糖尿病早期胃动力紊乱的发病。

关键词: 肥胖抑素, 弓状核-海马神经通路, 胃运动, 糖尿病, 大鼠

Abstract: Objective: To investigate the obestatin neural projections from arcuate nucleus (ARC) to hippocampus in diabetic rats, and its effects on gastric motility and gastric emptying of rats. Methods: Diabetic model was established by fructose intake combined with streptozotocin injected intraperitoneally in healthy male Wistar rats. Diabetic rats were randomly divided into five groups: control group (NS group), 0.1, 1 and 10 pmol obestatin group, and obestatin + NBI27914 group, with 7 rats in each group. 0.5 μl saline (NS), obestatin (0.1 pmol, 1 pmol, 10 pmol) or the mixture (10 pmol obestatin + 60 pmol NBI27914) was injected into the hippocampus respectively, the gastric motility was recorded immediately after administration, and the gastric emptying was studied 15 min later. ARC-hippocampus obestatin neural pathway and ARC obestatin mRNA expression were compared between normal and diabetic rats with fluorogold (FG) retrograde tracing and immunofluorescence histochemical staining. Results: Compared with normal rats, the number of ARC FG/obestatin double labeled neurons and the expression level of ARC obestatin mRNA were decreased significantly in diabetic rats (P<0.05); Obestatin could inhibit gastric motility and gastric emptying in a dose-dependent manner (P<0.05~0.01) and the effects of obestatin could be partially blocked by NBI27914, an antagonist of corticotropin releasing factor receptor 1 (CRFR1) (P<0.05). Compared with normal rats, the inhibitory effects of obestatin on gastric motility and gastric emptying were significantly decreased in diabetic rats (P<0.05). Conclusion: There is an obestatin neural pathway between ARC and hippocampus, which participates in the regulation of gastric motility and gastric emptying in diabetic rats, and CRFR1 signal pathway is involved in this process. The damage of this neural pathway may participate in gastric motility dysfunction in early stage of diabetes.

Key words: obestatin, ARC-hippocampus obestatin neural pathway, gastric motility, diabetes, rat

中图分类号: 

版权所有 © 2015 《中国应用生理学杂志》编辑部
京ICP备16058274号-1
地址:天津市和平区大理道1号,邮编:300050  电话:022-84655184  E-mail:tjzgyish@163.com
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn